IBM unveils new cloud based patent and IP analytics software
2 mins read
IBM has announced new analytics software and services designed to help companies develop and more effectively use intellectual property, scientific literature and molecular data.
Until recently, chemical data stored in patents was not available in a format accessible to computers, but by providing rapid access to worldwide patent data, researchers will be able to tap into one of the most extensive sets of data available to explore new innovations.
The company's cloud computing based business analytics and optimisation strategic IP insight platform (SIIP) technology can read and understand molecular structures drawn in chemical compound form – a key differentiator from existing patent search tools. Automated curation makes important data rapidly searchable and enables researchers to visualise chemical compounds in ways that were not previously possible.
SIIP enables organisations to quickly mine and use information in scientific literature and patents by bringing together much of the global patent information in one place and applying advanced analytics. One example is its ability to automatically use image analysis and enhanced optical recognition of chemical images and symbols to extract information from patents and literature upon publication. This is a task that can take months to complete manually, but can be done rapidly by using the new technology.
The platform can extract molecules and chemical information from patents, abstracts and publications within 24 hours of their publication, allowing for near real time access to information. The system has extracted more than 200million chemical instances from more than 30m patents and scientific abstracts and articles from around the globe.
"In the competitive R&D environment, it's critical to respond quickly to changes in the patent landscape and quickly analyse data," said John Kinney, PhD, fellow, DuPont. "IBM SIIP is a very powerful tool for allowing us to evaluate the strengths and weaknesses of our different research programs and to help focus our resources on the most promising areas."
Using the IBM SmartCloud, deep analytics tools are applied against patent documents from the US Patent and Trademark Office, European Patent Office and World Intellectual Property Organization and the public domain portion of scientific abstracts from the US National Library of Medicine's MEDLINE database. According to IBM, it can help identify new market opportunities, potential collaboration partners and merger and acquisition candidates.
SIIP has been used by hundreds of intellectual property experts across the company and many of the world's top life sciences companies are also using it across their R&D and IP divisions.
"IBM SIIP was designed to help transform the innovation process across a range of industries by making it feasible to look at all the information that exists today and all the research that has already been carried out," said Chris Moore, global business analytics and optimization leader, IBM Global Business Services. "It provides a new approach to finding and correlating critical information through the combination of underlying data, deep analytics, delivery via the cloud as well as customised services to help research and development organisations fundamentally change their business."
